Skip to main content
Figure 2 | Journal of Hematology & Oncology

Figure 2

From: Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery

Figure 2

Incidence of neutropenic events in US and EU patients. Incidence of grade 3 and 4 CIN and FN in US (N = 68) and EU (N = 47) patients during the first 4 cycles of chemotherapy. Patients with grade 4 CIN were not counted as having grade 3 CIN. Error bars represent 95% CIs. CIN chemotherapy-induced neutropenia; FN febrile neutropenia; CI confidence interval.

Back to article page